2nd Fungal Meningitis Death Reported In MD - 47 ABC - Delmarva's Choice

2nd Fungal Meningitis Death Reported In MD

Posted: Updated:

BALTIMORE, Md. - The Centers for Disease Control and Prevention reports that there has been another death in Maryland from fungal meningitis related to recalled medications.
    
The CDC website, which was updated on Monday, shows Maryland with two deaths, with the second apparently reported within the past week. Maryland health officials had reported the first death in October.
    
A spokeswoman for the Maryland Department of Health and Mental Hygiene said Monday night that she did not have information about the most recent death. A spokeswoman for the CDC said the agency gets the mortality information from state health departments.
    
The CDC reports that nationwide, 590 cases of illnesses, including 37, deaths have been linked to a specialty pharmacy.
    
The New England Compounding Center distributed the contaminated pain injections.

(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

  • ContestsMore>>

  • Skybox Giveaway - August 11

    Skybox Giveaway - August 11

    Win a SkyBox for you and 24 of your closest family and friends!More >>
    Win a SkyBox for you and 24 of your closest family and friends!
    More >>
  • Midway Speedway Giveaway

    Midway Speedway Giveaway

    Thursday, June 26 2014 7:57 AM EDT2014-06-26 11:57:18 GMT
    Enter to win a Midway Speedway Four Person Park Pass This includes all day at the waterpark, four choice tickets (good for any ride or attraction) and a round of fire mountain golf. Rules No purchaseMore >>
    Enter to win a Midway Speedway Four Person Park Pass This includes all day at the waterpark, four choice tickets (good for any ride or attraction) and a round of fire mountain golf. Rules No purchaseMore >>
Powered by WorldNow
Powered by WorldNow All content © Copyright 2000 - 2014 WorldNow and WMDT. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.